
The Merkel cells, which are located at the base of the epidermis (the outermost layer of the skin), are the source of Merkel cell carcinoma (MCC), an uncommon and aggressive form of skin cancer. These cells contribute to touch perception and are linked to nerve endings. When MCC develops on sun-exposed skin, it usually appears as a rapidly growing, painless nodule on the face, head, or neck.
Due to its high level of aggression and ability to spread quickly to other regions of the body (metastasise), Merkel Cell Carcinoma (MCC) must be treated promptly. Treatment effectiveness and better results are more likely to occur when the earlier MCC is identified and treated. Postponing treatment might cause the cancer to spread, making it harder to manage and decreasing the chances of survival.
The patient's quality of life can be significantly enhanced, metastases can be avoided, and the possibility of recurrence can be reduced with early intervention, usually through surgery, radiation, or immunotherapy.
Early identification and treatment are crucial for MCC patients to have the best chance of recovery.
The exact cause of Merkel cell carcinoma (MCC) isn't completely understood, but several factors are involved in its development:
Causes
Risk Factors
In Malaysia, immunotherapies, in addition to radiation therapy and surgical excision, are helping to advance the treatment of Merkel Cell Carcinoma (MCC). Malaysian healthcare is implementing biomarker-driven ways to tailor care, closely aligning with international norms to improve outcomes, even while novel approaches like oncolytic virus and NK cell-based treatments are still emerging.
Taking proactive steps to shield your skin from damaging UV rays and preserving the general health of your skin is key to preventing MCC. Here are some tips:
Sun Protection
Regular Skin Checks
Healthy Lifestyle
Generally, Merkel cell carcinoma (MCC) treatment depends upon your overall health and the stage.
Mohn Surgery: It's a precise procedure that preserves as much healthy tissue as possible while removing the tumour and skin layers.
Wide Local Excision: This procedure removes the tumour and some surrounding healthy tissue.
Lymphadenectomy (Lymph Node Dissection): Lymph nodes are removed if the cancer has spread to them.
Immunotherapy : Immunotherapy restores your immune system to help fight the cancer.
Cost Start From USD 15000 - USD 50000Explore Options
Radiation Therapy- Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy.
Chemotherapy : Advanced or metastatic MCC may be treated with conventional chemotherapy medications, although these are less frequently utilised than immunotherapy or targeted therapy. Chemotherapy kills cancer cells that divide quickly and can be given orally or intravenously.
Cost Start From USD 1500 - USD 3500Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Kuala Lumpur, Malaysia
Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.

Kuala Lumpur, Malaysia
Prince Court is a private medical facility in the center of Kuala Lumpur that has 277 individual beds. Our dedication is to provide you with the best treatment possible from the time you arrive until you depart, healthier and happier. We are well-known for our top-notch facilities, cutting-edge technology, and friendly customer service.

Kuala Lumpur, Malaysia
Subang Jaya Medical Center is renowned for pioneering radiation oncology treatments and infrastructure in Malaysia. The hospital also has a state-of-the-art Cancer Radiosurgery Centre (CRC), which is fully furnished with the latest medical technology for cancer detection, monitoring, and treatment.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Depending on the size of the tumour, the stage at diagnosis, and the extent of the cancer's spread, a person with Merkel Cell Carcinoma (MCC) may have a shorter life expectancy.
After radiation therapy and surgery, the prognosis for early-stage MCC is generally good, with a high survival rate. Despite recent dramatic improvements in survival rates due to immunotherapy and targeted treatments, the outlook for advanced or metastatic MCC can be more cautious.
Localised MCC has a 5-year survival rate of 60–80% overall, whereas advanced stages have a lower survival rate.
Like other Asian nations, Malaysia has an extremely low incidence of Merkel cell cancer. Better early detection and management, however, are being promoted by awareness of and adherence to international treatment guidelines.
MCC, or Merkel cell carcinoma, is characterised by its aggressiveness and quick proliferation. In addition to distant organs like the brain, liver, lungs, and bones, it can swiftly spread to neighbouring lymph nodes. Controlling the spread and enhancing results depend heavily on early detection and timely treatment.
Curing Merkel cell cancer (MCC) is possible, mainly if diagnosed early and treated. With a greater chance of successful treatment, the prognosis for localised MCC is better. However, when the cancer advances to more advanced stages, the likelihood of a cure declines.
There is little information on the prognosis of Merkel cell carcinoma (MCC), an uncommon but severe skin cancer, in Malaysia. The importance of early detection and treatment is highlighted because 5-year survival rates vary significantly between countries according to the diagnosis stage.
The size, location, and presence or absence of lymph nodes of the tumour all affect recovery time following surgery for Merkel cell carcinoma (MCC) in Malaysia.
Malaysia has sophisticated diagnostic methods for Merkel cell cancer (MCC), such as sentinel lymph node biopsies, skin biopsies, imaging tests, and CT and PET scans.
Malaysia is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs compared to several Western nations.
Malaysia's healthcare system accepts patients from abroad and provides excellent MCC treatments at many clinics and hospitals.
Yes, many hospitals in Malaysia offer in-person and online consultations to foreign patients who want a second opinion. You can get support by speaking with a medical tourism facilitator at MediGence to select the best doctor and facility. It provides specialised rehabilitation programs.

Medical Oncologist
14 Years of Experience
One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More
Last Reviewed - January 2026